Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
None of the patients were treated with bisphosphonates or other osteoporosis medications prior to biopsy.Clinical characteristics of the three patients with APS1CharacteristicPatient 1Patient 2Patient 3GenderFemaleMaleMaleAge (year)384725Height (cm/Z-score)152/− 2.9167/− 2.3175/− 0.9BMI (kg/m2)22.220.916.2S-Ca-ion (mmol/L)1.11 (1.16 to 1.30)1.15 (1.16 to 1.30)1.19 (1.16 to 1.30)P-Pi (mmol/L)1.35 (0.71 to 1.53)0.7 (0.71 to 1.53)1.29 (0.71 to 1.53)S-D-25-OH (nmol/L)65 (> 50)90 (> 50)128 (> 50)P-Cr (μmol/L)82 (50 to 90)97 (60 to 100)78 (60 to 100)Lumbar spine BMD T-score + 1.6− 1.7− 3.3Whole body BMD T-score + 1.2− 2.8− 3.5Femoral neck BMD T-score + 1.0− 2.2− 2.9Radial total vBMD T-score− 1.4− 4.9− 1.5Radial trabecular vBMD T-score− 0.3− 1.3 + 0.7Radial cortical vBMD T-score + 1.3− 1.8 + 1.2AIRE genotypec.769C > T/c.769C > Tc.769C > T/c.769C > Tc.769C > T/c.967_979del13Disease manifestations (duration in years)Hypoparathyroidism (33), adrenal insufficiency (30), hypogonadism (21), hypothyroidism, autoimmune gastritis, hepatitis (inactive), vitiligo, alopecia, recurrent oral candidiasis, intestinal dysfunction, gallbladder stonesAdrenal insufficiency (40), hypoparathyroidism (5), recurrent oral candidiasis, iritis, alopecia, autoimmune gastritis, intestinal dysfunctionHepatitis (inactive), vitiligo, hypogonadism (11), exocrine pancreas insufficiency, growth hormone deficiency, diabetes, renal tubular acidosis (14), bronchiolitis associated with bronchiectasias, keratitis, recurrent oral candidiasis, enamel dysplasia, nail dystrophyHydrocortisone dose (mg/kg/day)0.290.34Only in case of stressOther medicationsCalcium, alfacalcidol, fludrocortisone, thyroxin, magnesium, contraceptive pills, vitamin B12, trimetoprime sulfa, ironCalcium, magnesium, alfacalcidol, potassium, vitamin B12Potassium, sodium bicarbonate, magnesium, vitamin D3, Sustanon, immunoglobulin G, Creon, trimetoprime sulfa, escitalopram, insulinS serum; Ca-ion ionized calcium; P plasma; Pi phosphate; D-25-OH 25-hydroxy vitamin D; Cr creatinine; BMD bone mineral density; vBMD volumetric bone mineral density; AIRE autoimmune regulator gene.
Source: Clinical Data. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Four of these seven patients were eligible for a bone biopsy procedure for research purposes, and three of them gave the informed consent to participate in the study.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases
Study design awaiting verification · Calcified Tissue International · 2023
Original publication title
Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases
© The Author(s) 2023
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Autoimmune polyendocrine syndrome type-1 (APS1) is characterized by autoimmune manifestations affecting different organs from early childhood on. Immunological abnormalities, the resulting endocrinopathies, and their treatments may compromise bone health. For the first time in APS1, we analyzed transiliac bone biopsy samples by bone histomorphometry and quantitative backscattered electron imaging in three adult patients (female P1, 38 years; male P2, 47 years; male P3, 25 years). All had biallelic mutations in the autoimmune regulator gene and in addition to endocrinopathies, also significant bone fragility.
Histomorphometry showed bone volume in the lower normal range for P1 (BV/TV, − 0.98 SD) and P3 (− 1.34 SD), mainly due to reduced trabecular thickness (TbTh, − 3.63 and − 2.87 SD). In P1, osteoid surface was low (OS/BS, − 0.96 SD); active osteoblasts and double labeling were seen only on cortical bone. P3 showed a largely increased bone turnover rate (BFR/BV, + 4.53 SD) and increased mineralization lag time (Mlt, + 3.40 SD). Increased osteoid surface (OS/BS, + 2.03 and + 4.71 SD for P2 and P3) together with a large proportion of lowly mineralized bone area (Trab CaLow, + 2.22 and + 9.81 SD for P2 and P3) and focal mineralization defects were consistent with abnormal mineralization.
In all patients, the density and area of osteocyte lacunae in cortical and trabecular bone were similar to healthy adults. The bone tissue characteristics were variable and included decreased trabecular thickness, increased amount of osteoid, and abnormal mineralization which are likely to contribute to bone fragility in patients with APS1.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00223-023-01077-0.
Authors’ abstract
Autoimmune polyendocrine syndrome type-1 (APS1) is characterized by autoimmune manifestations affecting different organs from early childhood on. Immunological abnormalities, the resulting endocrinopathies, and their treatments may compromise bone health. For the first time in APS1, we analyzed transiliac bone biopsy samples by bone histomorphometry and quantitative backscattered electron imaging in three adult patients (female P1, 38 years; male P2, 47 years; male P3, 25 years). All had biallelic mutations in the autoimmune regulator gene and in addition to endocrinopathies, also significant bone fragility.
Histomorphometry showed bone volume in the lower normal range for P1 (BV/TV, − 0.98 SD) and P3 (− 1.34 SD), mainly due to reduced trabecular thickness (TbTh, − 3.63 and − 2.87 SD). In P1, osteoid surface was low (OS/BS, − 0.96 SD); active osteoblasts and double labeling were seen only on cortical bone. P3 showed a largely increased bone turnover rate (BFR/BV, + 4.53 SD) and increased mineralization lag time (Mlt, + 3.40 SD). Increased osteoid surface (OS/BS, + 2.03 and + 4.71 SD for P2 and P3) together with a large proportion of lowly mineralized bone area (Trab CaLow, + 2.22 and + 9.81 SD for P2 and P3) and focal mineralization defects were consistent with abnormal mineralization.
In all patients, the density and area of osteocyte lacunae in cortical and trabecular bone were similar to healthy adults. The bone tissue characteristics were variable and included decreased trabecular thickness, increased amount of osteoid, and abnormal mineralization which are likely to contribute to bone fragility in patients with APS1.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00223-023-01077-0.
Publication and source details
Original title: Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases
Saila Laakso; Tong Xiaoyu; Stéphane Blouin; Petra Keplinger; Ville-Valtteri Välimäki; Heikki Kröger; Outi Mäkitie; Markus A. Hartmann
Calcified Tissue International · 2023
© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.http://dx.doi.org/10.13039/501100005878Terveyden Tutkimuksen ToimikuntaAustrian social health insurance fundHelsinki University Hospitalhttp://dx.doi.org/10.13039/501100005744Lastentautien Tutkimussäätiöhttp://dx.doi.org/10.13039/100008723Suomen Lääketieteen Säätiöhttp://dx.doi.org/10.13039/100015736Folkhälsanin Tutkimussäätiöhttp://dx.doi.org/10.13039/501100009708Novo Nordisk FondenResearch funds of the Austrian workers compensation boardhttp://dx.doi.org/10.13039/501100006306Sigrid Juséliuksen SäätiöUniversity of Helsinki including Helsinki University Central HospitalOpen Access funding provided by University of Helsinki including Helsinki University Central Hospital.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T20:02:19.236497+00:00
DOI: 10.1007/s00223-023-01077-0 · PMC10198912